Abstract:Liver transplantation is amongst the most challenging surgeries for the anesthesiologist to manage. Due to advances in medical, surgical and perioperative management, 1-year survival following transplant is greater than 90%. At 5 years, more than 75% of liver transplant recipients survive, making it one of the most successful organ transplant procedures. The majority of the body’s organ systems are affected by end-stage liver disease (ESLD), mandating an in-depth knowledge of cerebral, cardiac, pulmonary and renal physiology when caring for these patients. Additionally, transplant surgery is associated with significant coagulopathy and blood loss that requires familiarity with blood product resuscitation. This chapter describes the surgical approach to liver transplant and examines the effects of ESLD by organ system. Extensive considerations are reviewed in this chapter including preoperative evaluation, intraoperative management, and the author’s preferred technique to provide a stepwise approach for liver transplantation. Table 72.1 provides a summary of anesthesia considerations in patients undergoing Liver Transplantation.Summary of anesthesia considerations in patients undergoing liver transplantationPlan/preparation/adverse eventsReasoning/managementPreoperative evaluation (see Table 72.2)Room-air ABG, contrast-enhanced TTE, CXR, PFTs, CT chestECG, TTE, ± noninvasive stress testingCBC, PT, PTT, INR, fibrinogen, d-dimerSerum BUN, serum Cr, BMPPositionSupineAccess≥1 14- or 16-gauge IV—Rapid fluid and blood product administrationArterial line—Anticipation of hemodynamic instability, frequent blood sampling, vasoactive drug administrationCentral venous catheter—CVP and PAP transduction, rapid fluid and blood product administration, vasoactive drug administrationGETA IV inductionEven if metabolism and/or excretion are hepatic, duration of action determined by redistribution RSIIncreased risk for regurgitation and aspiration MaintenanceIsoflurane or sevoflurane preferred given no significant decrease in hepatic blood flow or O2 deliveryProcedural adverse events AspirationRSI as above CoagulopathyTransfuse blood products to approximate goals of INR < 3.5, platelets > 20, and fibrinogen > 100 and clinical coagulation status HemorrhageTransfuse pRBCs to goal of hematocrit > 25Rapid infuser should be available HypotensionRelative hypovolemia during dissection phase, euvolemia after; titrate vasopressors to effect Hyperkalemic cardiac arrestApply defibrillation pads before induction; send ABGs q20–30 min during anhepatic phase; administer Ca2+, dextrose, and insulin as indicated Postreperfusion syndromeTitrate inotropes and vasopressors to effectPostoperative and post-discharge considerations ExtubationMay consider if hemodynamically stable and no significant transfusion requirements

Perioperative management of adult living donor liver transplantation: Part 1 - recipients

Laparoscopy-Assisted Versus Open Hepatectomy for Live Liver Donor: Systematic Review and Meta-Analysis

Exploring Anesthesiology Management of Living Donor Liver Transplantation: Survey From the Society for the Advancement of Transplant Anesthesia and the Korean Society for Transplantation Anesthesiologists

The Perioperative Management of Living Donor Liver Transplantation

Laparoscopic Donor Hepatectomy for Adult Living Donor Liver Transplantation Recipients

Donor safety in living donor liver transplantation: The Korean organ transplantation registry study

[Adult to Adult Living Donor Liver Transplantation for Decompensated End Stage Liver Disease].

Outcomes of 6000 living donor liver transplantation procedures: a pioneering experience at ASAN Medical Center

The aim of donor safety: surgical approaches and current results

Adult living donor liver transplantation in Singapore: the Asian centre for liver diseases and transplantation experience

Initial Experience in Adult-to-adult Living Donor Liver Transplantation

Pre-operative assessment of living liver donors' liver anatomy and volumes

Anesthesia for Liver Transplantation

Surgical Methods in Living Donor Liver Transplantation:With Report of 50 Cases

Post-Operative Complications in Living Liver Donors: A Single-Center Experience in China.

Achieving 400 Living Donor Liver Transplantations Annually During the COVID-19 Pandemic: A Single-Center Experience

Current Trends in Live Liver Donation

Asian Pacific Association for the Study of the Liver clinical practice guidelines on liver transplantation

Current trends in live liver donation.

Safety Analysis of Living Related Live Donors in Kidney Transplantation